SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052966
Filing Date
2020-11-10
Accepted
2020-11-10 16:13:18
Documents
79
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vir-10q_20200930.htm   iXBRL 10-Q 3498554
2 EX-10.3 vir-ex103_150.htm EX-10.3 35723
3 EX-10.4 vir-ex104_149.htm EX-10.4 4475
4 EX-31.1 vir-ex311_6.htm EX-31.1 21006
5 EX-31.2 vir-ex312_9.htm EX-31.2 20895
6 EX-32.1 vir-ex321_8.htm EX-32.1 9690
7 GRAPHIC gl3uvrmphws2000001.jpg GRAPHIC 2815
8 GRAPHIC gswdjapl3b0o000001.jpg GRAPHIC 2839
  Complete submission text file 0001564590-20-052966.txt   11086115

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA vir-20200930.xsd EX-101.SCH 85450
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vir-20200930_cal.xml EX-101.CAL 61198
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vir-20200930_def.xml EX-101.DEF 342366
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE vir-20200930_lab.xml EX-101.LAB 601269
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vir-20200930_pre.xml EX-101.PRE 485831
14 EXTRACTED XBRL INSTANCE DOCUMENT vir-10q_20200930_htm.xml XML 1677913
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39083 | Film No.: 201301258
SIC: 2836 Biological Products, (No Diagnostic Substances)